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Abstract. Schistosomiasis is a blood parasitic disease caused by trematode parasites of the genus Schistosoma.
Schistosomamansoni is one of themain contributors of the disease and 90%of the global burden of schistosomiasis is in
Africa. Mass drug administration (MDA) has been implemented to reduce the disease burden in endemic areas. Because
of MDA, the diagnostic sensitivity and specificity for classical diagnostic tests are reduced. In any disease situation,
diagnosis is vital in determining asymptomatic, concurrent, current, new, and reinfection cases to evaluate the efficacy of
any control program. We have evaluated the positive infection for S. mansoni from filtered urine samples collected from
Zambian school children after MDA using loop-mediated isothermal amplification (LAMP) and compared its sensitivity
and specificity with polymerase chain reaction (PCR). One hundred eleven urine samples collected from school children
aged between 7 and 15 years from Siavonga district in southern Zambia were evaluated by PCR and LAMP for DNA
extracted by two different protocols (filter-based versus crude extraction). The infection prevalence was 77% with PCR
andalmost 94%withmansoni-LAMP.Also, LAMPdetected16%(Qiagenextraction) and10%(LAMP-Procedure forUltra
Rapid Extraction) more positive S. mansoni infection than PCR. We have demonstrated the efficacy of LAMP in a
laboratory setup after MDA. The possible inclusion of LAMP as a field-based point-of-care test for surveillance can
provide reliable prevalence of schistosomiasis after MDA and help in determining the efficacy of a control program.
INTRODUCTION
The London Declaration 2020 aims to implement interven-
tions necessary to control or eliminate several neglected
tropical diseases, including schistosomiasis.1 Schistosomia-
sis in Africa is an ongoing public health problem, which cur-
rently infects close to 300 million individuals and more than
700 million people are at risk of getting infected.2 The most
prominent human schistosome, Schistosoma mansoni has
been endemic in 54 countries,3 mostly in Africa. There is a
strong age-specific relationshipwith the human population. In
the age group of 6–15 years, the infection prevalence and
intensity peak, resulting into consequences of growth and
cognition delays, attention deficit, poor performance in
school, and a negative effect on the overall growth and quality
of a child’s life.4
Currently, schistosomiasis has been treated routinely
with mass drug administration (MDA5). Because of MDA
control intervention, the detection limit for remaining or new
S. mansoni infection poses a challenge for gold standard
(WHO-recommended) tests and is often missed.6 The gold
standard diagnostic test, Kato-Katz (KK—parasitological) is
low cost and most commonly used, but it lacks sensitivity
for low endemic areas and for the posttreatment situation.7
This diagnostic problem is exacerbated as elimination cam-
paigns progress, and the test becomes less effective and will
miss out detection of asymptomatic carriers, which could
be the likely source of continued transmission. Evaluation
of control programs and disease reemergence needs more
sensitive, specific, easy-to-use diagnostic tests.8 To address
this issue, there is a need to develop a highly sensitive
diagnostic method, which will use species-specific DNA de-
tection equally well in high-, medium-, and low-intensity in-
fection settings.
Recently, tests involving nucleic acid amplification, such as
polymerase chain reaction (PCR), have showngreat sensitivity
and specificity forS.mansoni for various types of samples.9–12
We have previously detected an S. mansoni–specific cell-free
repeat DNA fragment captured on filter paper through urine
filtration via PCR.6,13,14 This approach is devoid of stool
testing and reliance on eggs.15 The inherent technological
limitations of PCR, such as longer time requirement, re-
quirement of gel electrophoresis for visualization, expertise in
molecular biology, and expensive equipment, make it unus-
able in the field or in resource-poor endemic settings.16,17
It has, however, been proposed that loop-mediated iso-
thermal amplification (LAMP) can be used as a point-of-care
(POC) assay for field diagnostics.18 Loop-mediated iso-
thermal amplification uses four primers which amplify six dif-
ferent regions of the target DNA,which occurs at one constant
temperature, and positive reactions will yield changes in color
or turbidity.19 It is more resistant to inhibitors than PCR be-
cause it uses Bst polymerase. The sensitivity of LAMP has
been demonstrated to be greater than that of PCR.20 Loop-
mediated isothermal amplification reactions occur quicker
than PCR, amplify DNA fragments independent of the stan-
dard thermocycler and electrophoresis, and remove the need
for special reagents. This saves timeandmoney. TouseLAMP
as a POC diagnostic test, commercially available Procedure
for Ultra Rapid Extraction (PURE; Figure 1) kit (Eiken Chemical
Co., Ltd, Tokyo, Japan) has been used to rapidly isolate DNA
from clinical samples without potential inhibitors.16,21 This
procedure has been used for tuberculosis,16 pneumonia,21
malaria,9,16,20 and other infectious diseases.
In this study, we have evaluated the performance of LAMP
(as POC diagnosis) for S. mansoni by amplifying the species-
specific cell-free repeat DNA fragment (121-bp Sm1-7 repeat
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fragment, GenBank: M61098.1) from filtered urine samples
collected from Zambian school children after MDA and com-
pared its sensitivity and specificity against PCR. In addition,
two different DNA extraction kits (Qiagen and PURE kits) were
used for isolation of DNA, which have been compared and
evaluated to see the impact of extracted DNA on the di-
agnostic performances of LAMP and PCR.
MATERIALS AND METHODS
Study design and sample population. This was a cross-
sectional study conducted in July 2016 in Siavonga District in
the Southern Province of Zambia. The sample population in-
volved school children aged 7–15 years, who provided con-
sent to participate in the study from their parents either
verbally or in written. Urine and stool samples were collected
1 month after the administration of praziquantel (given at
40 mg/kg). Ethical clearance for conducting this study was
obtained from the Institutional Review Board (IRB) of ERES
Coverage of Zambia (IRB # 2016-Apr-002) and from Mar-
quette University, Milwaukee, WI (IRB # HR-3116).
Sample collection. A total of 111 urine samples were col-
lected from school children (50 males and 60 females). The
same reference number was used for two different sample
types, and two plastic cups were provided in two consecutive
days to the participants for collection of urine on the first day
and stool on the second day. About 30–40 mL of urine was
filtered through Whatman #3 filter paper (Sigma-Aldrich,
St. Louis, MO), which was marked with the same reference
number before filtering the urine. Filter paperswere then left to
dry under a fly-proof net and on drying, packed in individual
Ziploc bags with desiccant and shipped to Marquette Uni-
versity,Milwaukee,WI,where theywere stored in a refrigerator
at 4C for further testing. For every participant, age, gender,
locality, and result of the parasitological test were recorded.
Parasitological examination of stool samples for
S. mansoni eggs. The Kato-Katz kit, a WHO-recommended
kit (WHO, Geneva, Switzerland) was used to detect the pres-
ence of S. mansoni eggs.22 Two consecutive stool smears
were evaluated for the presence of eggs. Briefly, feces were
pressed through a mesh screen to remove large particles. A
portion of the sieved stool sample was then transferred to the
hole of a template placed on a slide. After filling the hole on
the template, the template was removed, and the remaining
sample was covered with a piece of cellophane previously
soaked in glycerol–malachite green. The slide was then ex-
aminedunder amicroscope for thepresenceof helminth eggs.
DNA extraction and quantification. One hundred eleven
filter papers were used for DNA extraction by the QIAmp
DNeasy® Blood and Tissue Kit (Qiagen, Hilden, Germany) and
by the LAMP-PURE extraction kit (Eiken Chemical Co., Ltd).
For Qiagen extraction, each filter paper disc was divided into
four quadrants, and 12 punches (∼1 mm in diameter) were
removed from one quadrant using a regular paper punch. The
scissors and paper punch were washed with 10% bleach and
water between each sample to prevent any contamination.
FIGURE 1. Loop-mediated isothermal amplification-Procedure for Ultra Rapid Extraction DNA extraction kit. (A) Three components of the
extraction kit. (B) All attached components for DNA extraction represents a closed environment for rapid DNA extraction. This figure appears in
color at www.ajtmh.org.
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The filter paper punches were mixed with 800 μL of DNA–
RNA-free water (Sigma-Aldrich) and heat-shocked at 95C
for 10 minutes. The samples were then left on a shaker over-
night to finish the extraction with the Qiagen kit the next day
by following the manufacturer’s protocol. All extracted DNA
samples were quantified via NanoDrop (Thermo Fisher Sci-
entific, Waltham, MA) and aliquoted into two tubes of 50 μL
each. The stock and aliquot DNA were stored at −20C for
amplification.
The LAMP-PURE extraction kit composed of three different
units, namely, heating tube, adsorbent tube, and injection cap
(Figure 1). For extraction, 800 μL of the sample was added to
the heating tube and attached with the adsorbent tube, as
the heating was already performed. The powder in the ad-
sorbent tube removed any possible inhibitor. Then, the in-
jection cap was attached. The adsorbent tube was squeezed
over a 1.5-mL Eppendorf tube, and approximately 600 μL
of the extracted DNA was collected per sample. All samples
were quantified. Loop-mediated isothermal amplification-
Procedure for Ultra Rapid Extraction extraction was a crude
process, which resulted in very high DNA concentrations; all
samples were subjected to dilution using the formula: C1V1 =
C2V2 to concentrations of approximately 5 ng/μL of 100 μL
each for two aliquots. One aliquot for each sample was then
re-quantified to confirm the concentration. The stock and al-
iquot DNA were then stored in a −20C freezer for PCR and
LAMP amplification.
Amplification of theS.mansoni repeat DNA via PCRand
LAMP. All 111 samples extracted by the Qiagen kit and the
LAMP–PURE kit were amplified by PCR and LAMP. Poly-
merase chain reaction amplification was carried out in 10 μL
volume with the S. mansoni genomic DNA (BEI Resources,
Manassas, VA) as the positive control, the Schistosoma hae-
matobium genomic DNA (BEI Resources) as the negative
control, template DNA controls were collected from people in
the United States, who have never been exposed to schisto-
somiasis, and nuclease-free water as the water control
(Sigma-Aldrich). For PCR amplification, the reaction volume
consisted of 5 μL of the PCRmastermix (NewEnglandBiolabs
Inc., Ipswich, MA), 0.5 μL (10 μM concentration) each of for-
ward and reverse primers, 0.5 μL of 25 mM MgCl2, 2 μL of
DNA (concentration: 4–6 ng/μL), and rest nuclease-freewater.
The amplification profile included initial denaturation at 95C
for 10minutes; then35cycles at 95C for 30 seconds, 57C for
90 seconds, and 72C for 45 seconds; and a final extension at
72C for 10 minutes. The same PCR amplification protocol
and arrangement was followed for both Qiagen- and LAMP–
PURE-extracted DNA. To confirm amplification and correct
amplicon size, PCR products were visualized on a 2% aga-
rose gel stained with SYBR Green (Thermo Scientific) with a
50-bp reference DNA marker (New England BioLabs Inc.).
Loop-mediated isothermal amplification was performed
using the LAMP ready-to-use buffermix for two separateDNA
templates. The 2× ready-to-use buffer mix was composed of
10× LAMP buffer (Eiken Chemical Co., Ltd), 5 M betaine
(Sigma-Aldrich), and 10 mM dNTPs (Promega, Madison, WI).
The reaction volume for all LAMP amplification was 10 μL,
which was composed of 4 μL of ready mix buffer, 0.5 μL each
of LAMP primers (5 pmoles of F3 and B3 and 40 pmoles of
forward inner primer [FIP] and backward inner primer [BIP]),
1 μL of Bst DNA polymerase (New England BioLabs Inc.),
2–3μLof extractedDNA (4–5ng/μL in concentration), and1μL
of nuclease-free water. The amplification was carried out for 2
hours at 63C with inactivation for 5 minutes at 80C. Loop-
mediated isothermal amplification products were detected by
adding 1 μL of SYBR Green (1:20 dilution), and a picture was
taken using a cell phone. To confirm the correct amplified
product, all LAMP products were visualized on 2% agarose
gel stained with SYBR Green and run with a 50-bp reference
ladder. Gel pictures were captured using the Azure c200
system (Azure Biosystems, Dublin, CA). The primers used for
PCR and LAMP were reported in earlier publications.6,13
Statistical analysis. We performed quantitative assess-
ment to evaluate the sensitivity, specificity, disease preva-
lence, positive predictive value (PPV), negative predictive
value (NPV), and accuracy of PCR and LAMP amplification
for S. mansoni by comparing the two different extraction
methods. The abovementioned statistical analysis was
performed by comparing positive and negative infection
detection by KK and PCR and LAMP for two different DNA
extractions. Disease prevalence was determined based
on the number of positive cases by each diagnostic test
against the total number of samples evaluated. Accuracy
was determined based on the probability of a test of
TABLE 1
Detection of positive and negative infection by KK, PCR, and LAMP for Schistosoma mansoni for both Qiagen- and LAMP-PURE–extracted DNA
A. Comparison of positive and negative infection detection by PCR and LAMP
N: 111 samples PCR positive PCR negative LAMP positive LAMP negative
Qiagen 86 (77.5%) 25 104 (93.7%) 7
LAMP-PURE 86 (77.5%) 25 97 (87.4%) 14
B. Comparison of positive and negative infection detection by KK and PCR
N: 111 samples
PCR Qiagen
positive
PCR Qiagen
negative
PCR LAMP-PURE
positive
PCR LAMP-PURE
negative
KK positive 9 (8.1%) 25 7 (6.3%) 2
KK negative 77 (69.3%) 0 79 (71.8%) 23
C. Comparison of positive and negative infection detection by KK and LAMP
N: 111 samples
LAMP Qiagen
positive
LAMP Qiagen
negative
LAMP LAMP-PURE
positive
LAMP LAMP-PURE
negative
KK positive 9 (8.1%) 0 8 (7.2%) 1
KK negative 95 (85.6%) 7 89 (80.1%) 13
KK = Kato-Katz; LAMP-PURE = loop-mediated isothermal amplification-Procedure for Ultra Rapid Extraction; PCR = polymerase chain reaction.
80 PRICE, CYRS, AND OTHERS
correctly diagnosing as a positive case. For quantitative
analysis, MedCalc 12.4.0 (MedCalc Software, Ostend, Bel-
gium) was used. Data were processed through JMP 12
(JMP® v12, SAS Institute Inc., Cary, NC) and converted to
numerical values (1 = positive and 0 = negative) for statistical
analysis. JMP was also used to calculate the agreement
statistics by measuring the kappa value and Bowker’s
symmetry. The kappa coefficient determined the agreement
between two tests, where −1 = negative association, 0 =
random, and +1 = full agreement. The Bowker’s symmetry
was a disagreement statistic, which was trying to determine
the symmetry between two tests based on the χ2 approxi-
mation of the distribution of the test statistic.23
RESULTS
Detection of positive and negative infection by PCR and
LAMP for two different DNA extraction methods. When
evaluated for PCR amplification, both extraction methods
(Qiagen and LAMP-PURE) yielded the same number of posi-
tives and negatives. The positive infection rate was 77.5%
(86/111) with PCR for both DNA extractions, whereas it
was almost 94% (104/111) for Qiagen extraction and 87%
(97/111) for LAMP-PURE with LAMP amplification (Table 1).
Loop-mediated isothermal amplification detected more pos-
itive infections than PCR, 18 for Qiagen (16%more) and 11 for
LAMP-PURE (10% more; Table 1). The findings were con-
sistent with previous study findings about LAMP being more
sensitive than PCR.24
Detection of positive and negative infection by KK and
comparison against PCR and LAMP. The amplification by
PCR and LAMP for Qiagen extraction identified all of the
samples positively identified by KK, but yielded significantly
more positives by PCR (69.3%) and LAMP (85.6%), which
were eventually KK negative (Table 1). The amplification for
LAMP-PURE samples by PCR and LAMP also identified sig-
nificantly more KK-negative samples, but few KK positives
(two for PCR and one for LAMP) came out as negative
(Table 1).
Comparative analysis of efficacy for amplification
methods for different DNA extraction methods. Loop-
mediated isothermal amplification for Qiagen-extracted
samples yielded 18 more positive infections, which were
negative by PCR (total 86) for the same extraction. Similarly,
LAMP-PURE yielded 17 more positive infections than PCR
(total 80), although failed to detect six PCR-positive infections
(Table 2). When PCR for LAMP-PURE–extracted samples
were compared against PCR LAMP-PURE, only 74 were
matched for both,with overlap of negative amplification by the
one came out as positive by another amplification. Loop-
mediated isothermal amplification for both extracted DNA
improved the outcome with 91 positives for both extractions,
with the 13 remaining undetected for LAMP-PURE extraction
(came out positive for Qiagen). Loop-mediated isothermal
amplification-Procedure for Ultra Rapid Extraction–extracted
DNA resulted in some discrepancies for both PCR and LAMP
amplification (Table 2).
Disease prevalence estimation, comparison statistics,
and agreement statistics analysis. The diagnostic param-
eter calculation showed 100% sensitivity (95% CI: 96–100)
and 100% specificity (95% CI: 59–100) with 94% disease
prevalence for LAMP-Qiagen (Table 3). The predictive value
estimation and accuracy were also 100% for LAMP-Qiagen.
Polymerase chain reaction-Qiagen was the second best test
with 83% sensitivity (95% CI: 74–89) and 100% specificity
(95% CI: 59–100) and similar disease prevalence (94%). The
PPV was 100% for PCR-Qiagen, but the NPV (28%) and
accuracy (84%) were lower than those of LAMP-Qiagen
(Table 3). Loop-mediated isothermal amplification for LAMP-
PURE showed higher sensitivity (88%; 95% CI: 80–93) and
higher disease prevalence (94%), although it showed lower
specificity (only 14%; 95% CI: 0.4–58). These findings were
comparatively lower for PCR for LAMP-PURE with 79% sen-
sitivity (95% CI: 69–86), 31% specificity (95% CI: 9–61), 88%
TABLE 2
Diagnostic comparison of amplification efficacy by PCR and LAMP for Qiagen- and LAMP-PURE–extracted DNA for Schistosoma mansoni
LAMP-Qiagen
PCR-Qiagen
LAMP LAMP-PURE
PCR LAMP-PURE
Positive Negative Positive Negative
Positive 86 18 Positive 74 23
Negative 0 7 Negative 12 2
LAMP_LAMP
_PURE
LAMP-Qiagen
LAMP_LAMP_PURE
PCR-Qiagen
Positive Negative Positive Negative
Positive 91 6 Positive 80 17
Negative 13 1 Negative 6 8
LAMP-PURE = loop-mediated isothermal amplification-Procedure for Ultra Rapid Extraction; PCR = polymerase chain reaction.
TABLE 3
Comparison statistics measured for PCR and LAMP amplification for Schistosoma mansoni based on two different extraction techniques
PCR-Qiagen (95% CI) PCR_LAMP-PURE (95% CI) LAMP-Qiagen (95% CI) LAMP_LAMP_PURE (95% CI)
Sensitivity 83% (74–89%) 79% (69–86%) 100% (96–100%) 88% (80–93%)
Specificity 100% (59–100%) 31% (9–61%) 100% (59–100%) 14% (0.4–58%)
Prevalence 94% 88% 94% 94%
PPV 100% 90% 100% 94%
NPV 28% 16% 100% 7%
Accuracy 84% 73% 100% 83%
LAMP-PURE= loop-mediated isothermal amplification-Procedure for Ultra Rapid Extraction; NPV = negative predictive value; PCR = polymerase chain reaction; PPV = positive predictive value.
The infection prevalence identified by each extraction technique is highlighted in bold to emphasize the difference.
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disease prevalence, and lowest accuracy value (73%) of them
all (Table 3). The PPV values for all four combinations were
close and ranged from 90% to 100%. However, NPVs were
variable, as it was 100% for LAMP-Qiagen and significantly
lower for LAMP_LAMP-PURE (7%) and PCR_LAMP-PURE
(16%; Table 3).
Test positives for PCR-Qiagen were highly likely to be the
samewith LAMP-Qiagen, although LAMPwasmore sensitive
for Qiagen-extracted samples (Bowker = 18, P = 0.001). In
addition, moderate agreement (kappa = 0.38) was seen for
both PCR and LAMP amplification for Qiagen (Table 4). Sim-
ilarly, PCR for Qiagen and LAMP for LAMP-PURE showed
moderate agreement (kappa=0.30), but the test positivesmay
not be similar as evidenced from the Bowker’s symmetry
(5.26, P = 0.0218). On the other hand, 1) PCR-Qiagen and
PCR_LAMP-PURE and 2) LAMP-Qiagen and LAMP_LAMP-
PURE were highly unlikely to yield always the same result
(Table 4).
DISCUSSION
We found that LAMP ismore sensitive in detecting low-level
infections, especially after MDA. Using well-defined positive
and negative controls and 111 filtered urine samples col-
lected from school children after MDA, the LAMP assay for
the Qiagen-extracted DNA achieved 100% sensitivity, spec-
ificity, and accuracy with 94% disease prevalence (Table 3).
Moreover, LAMP-Qiagen detected 16% more positive in-
fection than PCR amplification for the Qiagen-extracted DNA
(Table 1). Polymerase chain reaction also performed well with
100% specificity and 83% sensitivity for Qiagen extraction.
The sensitivity of LAMP is being considered as 10 times higher
than PCR by previous study,24 and our findings are consistent
with such findings. The findings also signify the need for such
sensitive assays for low infection intensities, especially after
MDA, as it is evident from the performance of KK. The sensi-
tivity of PCR and LAMP (Qiagen extraction only) is eight and
11 times higher than that of KK for the samples evaluated for
this particular study (Table 1). In addition, the findings in our
study for PCR and LAMP amplification for PURE extraction
is consistent with findings reported elsewhere. The sensitivity
is high, ranging from 79% (PCR) to 88% (LAMP), but speci-
ficity is the issue (31% for PCR and only 14% for LAMP).
As PCR and LAMP both are sensitive molecular methods,
higher sensitivity is expected. The lower specificity could
probably be associated with the presence of inhibitors in the
extracted DNA.
The Qiagen kit is very reliable and produced quality DNA in
our previous studies. Also, it is a membrane-based DNA
extraction kit, which usually takes care of the inhibitors pre-
sent in extracted DNA along with some protein and other
cellular debris. On the other hand, PURE is an enclosed sys-
tem devoid of membrane, so there is less chance of contam-
ination, but higher chances of having impurities in the
extracted DNA. The possible presence of impurities in the
extracted DNA may have led to the misdiagnosis of positive
samples and regarded them as true negatives. The presence
of inhibitors could have hindered the amplification of the
species-specific repeat fragment by PCR and LAMP. Con-
sidering the fact that PURE has been designed for quick DNA
extraction, which is suitable for field, it can, thus, be an integral
part of LAMP diagnosis. Other studies have been planned to
address this issue specially to evaluate the efficacy of LAMP
amplification based on PURE extraction for asymptomatic
individuals.
This study, however,maynot provide a conclusive outcome
about LAMP’s superiority over PCR because of the limitation
of the sample size. To substantiate the assertion that LAMP is
superior over PCR, there would be a need to conduct studies
in various settings considering different prevalence rates of
schistosomiasis and with varying disease burdens among the
infected population. Another limitation of the study is the ab-
sence of baseline data that probably would have reflected the
efficacy of the MDA for this particular population.
To determine the species-specific amplification, we have
sequenced random samples to verify the amplified fragments
by both PCR and LAMP. All the sequences are matched
against NCBI GenBank, and they matched with the 121-bp
Sm1-7 repeat fragment (GenBank: M61098.1) for S. mansoni
with 100% identity. This indicates the specificity of the LAMP
primers and the uniquenessof the cell-free repeat fragment for
S. mansoni.
Misdiagnosis or underdiagnosis occurs often when the in-
fection level is low, and this is true for theMDAprogram,where
traditional tests usually fail to detect the remaining infection or
reinfection.25 This study shows the usefulness of the LAMP
assay in the diagnosis of these low-level infections after MDA,
which is evident from the poor performance of KK. This is
highly important in determining the applicability of LAMP as a
field diagnostic technique. Although LAMPmay not be able to
quantify the disease burden, but increased sensitivity and
specificity will aid into identification of the remaining infection
that has escaped the MDA. This will help in determining the
actual infection prevalence for the particular population going
through treatment andwill ultimately determine the efficacy of
the control program.Moreover, LAMP can be implemented as
an integrated diagnostic approach (POC test) for surveillance
and to determine the transmission foci by extending the
TABLE 4
Agreement statistics estimation (kappacoefficient andBowker symmetry test) comparing species-specificDNAamplificationbyPCRandLAMP for
both Qiagen- and LAMP-PURE–extracted DNA for Schistosoma mansoni
Comparison of diagnostic tests
Kappa coefficient Bowker’s symmetry test*
Degree of agreement 95% CI Symmetry of disagreement P-value†
PCR-Qiagen vs. LAMP-Qiagen 0.38 0.17–0.58 18 0.0001‡
PCR-Qiagen vs. PCR_LAMP-PURE −0.08 −0.25–0.09 0 1.0000
PCR-Qiagen vs. LAMP_LAMP-PURE 0.30 0.08–0.51 5.26 0.0218‡
LAMP-Qiagen vs. LAMP_LAMP-PURE 0.01 −0.17–0.19 2.58 0.1083
LAMP-PURE = loop-mediated isothermal amplification-Procedure for Ultra Rapid Extraction; PCR = polymerase chain reaction.
* Bowker’s symmetry test = this test checks for symmetry in two-way tables and the test decision is based on a χ2 approximation of the distribution of the test statistic.
† α level was set at 0.05.
‡ Significant. P-values are highlighted in bold.
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testing for infected snails. Using LAMP as a POC diagnosis to
determine the disease prevalence, especially after MDA, will
help stakeholders to make informed decision for control
intervention.
Given the advantages and demonstrated performance of
LAMP, we anticipate that it will be suitable to use not only for
resource-poor environments but also forwell-equippedhealth
facilities. Procedure for Ultra Rapid Extraction kit can also be
part of this process, and overall, LAMP-PURE can play an
important role in molecular xenomonitoring for S. mansoni.
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